Stempoint Capital’s Rezolute RZLT Stock Holding History

Stempoint Capital’s Portfolio RZLT Stock Details RZLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-917,630	Closed	-$8.63M	–	109
2025 Q3	$8.63M	Buy	917,630 +272,976	+42%	+$1.82M	1.73%	17
2025 Q2	$2.88M	Buy	+644,654	New	+$2.39M	0.92%	32

Other funds holding RZLT

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Stempoint Capital's RZLT Position: Q4 2025 in Review

Stempoint Capital sold out of Rezolute (RZLT) in Q4 2025, closing a stake of 917,630 shares — an estimated $8.63M sold.

Stempoint Capital first reported a position in RZLT in Q2 2025 and held it in 2 quarters. The position peaked at $8.63M in Q3 2025. 121 funds tracked by Wall St. Rank hold RZLT as of Q4 2025.

Stempoint Capital reported no remaining Rezolute position as of Q4 2025 after selling out during the quarter.
Stempoint Capital sold 917,630 Rezolute shares in Q4 2025, an estimated $8.63M.
Stempoint Capital first reported a position in Rezolute in Q2 2025 and held it in 2 quarters.
Stempoint Capital's Rezolute position peaked at $8.63M in Q3 2025.
121 funds tracked by Wall St. Rank held Rezolute as of Q4 2025.

Based on Stempoint Capital's 13F filing for Q4 2025, filed 17 Feb 2026.